Extended preservation of human liver grafts with UW solution.

PubWeight™: 3.99‹?› | Rank: Top 1%

🔗 View Article (PMC 2954660)

Published in JAMA on February 03, 1989


S Todo1, J Nery, K Yanaga, L Podesta, R D Gordon, T E Starzl

Author Affiliations

1: Department of Surgery, University Health Center of Pittsburgh, PA 15213.

Articles citing this

The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89

Liver transplantation (1). N Engl J Med (1989) 4.53

Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38

The point system for organ distribution. Transplant Proc (1989) 1.88

The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967). J Am Coll Surg (2002) 1.81

Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc (1991) 1.77

Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation (1991) 1.71

Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation (1989) 1.58

Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol (1989) 1.45

Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology (1990) 1.38

Endotoxemia and human liver transplantation. Transplant Proc (1989) 1.28

Comparison of UW with other solutions for liver preservation in dogs. Clin Transplant (1989) 1.20

Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Ann Surg (2000) 1.18

Disease gravity and urgency of need as guidelines for liver allocation. Hepatology (1994) 1.16

Transplantation. JAMA (1989) 1.11

The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. Transplant Proc (1991) 1.08

Consequences of cold-ischemia time on primary nonfunction and patient and graft survival in liver transplantation: a meta-analysis. PLoS One (2008) 1.07

Comparative evaluation of maintenance of cell viability of an experimental transport media "coconut water" with Hank's balanced salt solution and milk, for transportation of an avulsed tooth: An in vitro cell culture study. J Conserv Dent (2008) 0.99

Personal experience with the procurement of 132 liver allografts. Transpl Int (1989) 0.98

Themes of liver transplantation. Hepatology (2010) 0.98

Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant (1990) 0.94

Lazaroid U-74389G for 48-hour canine liver preservation. Transplantation (1996) 0.93

The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93

IGL-1 solution reduces endoplasmic reticulum stress and apoptosis in rat liver transplantation. Cell Death Dis (2012) 0.93

Liver transplantation--challenges for the future. West J Med (1991) 0.92

History of clinical transplantation. World J Surg (2000) 0.91

Determination and extension of the limits to static cold storage using subnormothermic machine perfusion. Int J Artif Organs (2013) 0.89

The effect of propolis as a biological storage media on periodontal ligament cell survival in an avulsed tooth: an in vitro study. Cell J (2013) 0.87

Trimetazidine: is it a promising drug for use in steatotic grafts? World J Gastroenterol (2006) 0.86

Liver transplantation in patients with previous portasystemic shunt. Am J Surg (1990) 0.86

Liver transplantation. Experience with 100 cases. West J Med (1991) 0.86

Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury. Surgery (2009) 0.85

Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution. World J Gastroenterol (2010) 0.84

Polyethylene glycol rinse solution: an effective way to prevent ischemia-reperfusion injury. World J Gastroenterol (2014) 0.83

Liver transplantation for primary biliary cirrhosis. Semin Liver Dis (1989) 0.83

Comparative Effects of Phosphoenolpyruvate, a Glycolytic Intermediate, as an Organ Preservation Agent with Glucose and N-Acetylcysteine against Organ Damage during Cold Storage of Mouse Liver and Kidney. ISRN Pharmacol (2013) 0.82

HLA matching effect in liver transplantation. Transplant Proc (1992) 0.82

Hepatic artery thrombosis following pediatric liver transplantation: Assessment of blood flow measurement in allografts. Clin Transplant (1989) 0.81

Modified simple cold storage of rat livers with UW solution. Transplantation (1994) 0.81

Is hepatic artery thrombosis after liver transplantation really a surgical complication? Transplant Proc (1989) 0.81

Procurement of liver allografts from non-heart beating donors. Transplant Proc (1990) 0.80

Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc (1995) 0.80

Improving Donor Livers by Inhibiting TNF-α Production. Ochsner J (2010) 0.79

Chronic Nicotine Exposure In Vivo and In Vitro Inhibits Vitamin B1 (Thiamin) Uptake by Pancreatic Acinar Cells. PLoS One (2015) 0.78

Hemodynamic and biochemical changes during normothermic and hypothermic sanguinous perfusion of the porcine hepatic graft. Transplantation (1990) 0.78

Cold ischemia time vs outcome of human liver transplantation using UW solution. Transplant Proc (1991) 0.77

Celsior versus University of Wisconsin preserving solutions for liver transplantation: postreperfusion syndrome and outcome of a 5-year prospective randomized controlled study. World J Surg (2011) 0.77

Phosphorus 31-nuclear magnetic resonance spectroscopy of rat liver during simple storage or continuous hypothermic perfusion. J Lab Clin Med (1992) 0.75

Pretransplant assessment of human liver grafts by plasma lecithin: cholesterol acyltransferase (LCAT) activity in multiple organ donors. Transpl Int (1992) 0.75

Hepatic mitochondrial function analysis using needle liver biopsy samples. PLoS One (2013) 0.75

Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. Am J Kidney Dis (1998) 0.75

Fluorometric study of the viability of rat liver grafts after simple cold storage with UW solution versus Euro-Collins solution. Transplant Proc (1991) 0.75

Levels of purine nucleoside phosphorylase (PNP) as a viability marker of nonparenchymal cells in cold preserved livers. Transplant Proc (1991) 0.75

HLA-DR matching effect in orthotopic liver transplantation under FK 506. Transplant Proc (1993) 0.75

The present state of liver transplantation and the future prospects for intestinal transplantation. Immunol Invest (1989) 0.75

Hyaluronate levels in donor organ washout effluents: a simple and predictive parameter of graft viability. Liver (1996) 0.75

Scanning electron microscopic study of cold-stored small bowel: comparison of Euro-Collins and Lactated Ringer's solutions. Dig Dis Sci (2003) 0.75

Articles cited by this

Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow. Surg Gynecol Obstet (1960) 11.73

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Principles of solid-organ preservation by cold storage. Transplantation (1988) 3.79


Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Extended preservation of the liver for clinical transplantation. Lancet (1988) 2.89

Procurement of cadaver donor organs: evisceration technique. Transplant Proc (1972) 2.40


Simple hypothermic preservation for transporting human livers long distances for transplantation. Report of 12 cases. Transplantation (1977) 2.08

Cadaveric renal transplantation: a technique for donor kidney removal. Br J Urol (1968) 2.05

Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc (1987) 1.90

72-hour preservation of the canine pancreas. Transplantation (1987) 1.55

Rapid Flush Technique for Donor Hepatectomy: Safety and Efficacy of an Improved Method of Liver Recovery for Transplantation. Transplant Proc (1988) 1.37

Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441. Gastroenterology (1988) 1.08

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice. J Exp Med (1975) 5.53

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

Fungal infections in liver transplant recipients. Transplantation (1985) 3.07

De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03

Responsiveness to HY antigen Ir gene complementation and target cell specificity. Immunol Rev (1977) 3.03

Experience with 150 liver resections. Ann Surg (1983) 3.01

A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

Death after transplantation; an analysis of sixty cases. Am J Med (1967) 2.99

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92

Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Liver transplantation in adults. Hepatology (1982) 2.89

Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet (1985) 2.88

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc (1993) 2.81

Successful liver transplantation from crossmatch-positive donors. Transplant Proc (1981) 2.80

Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80

The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76

Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Intern Med (1968) 2.72